Isopulegol

Isopulegol
Product Name Isopulegol
CAS No.: 89-79-2
Catalog No.: CFN70214
Molecular Formula: C10H18O
Molecular Weight: 154.2 g/mol
Purity: >=98%
Type of Compound: Monoterpenoids
Physical Desc.: Oil
Targets: GABAA receptor | ATP | Potassium channel
Source: The herbs of Mentha haplocalyx Briq.
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price: $30/20mg
Isopulegol has antioxidant, and neuroactive properties. It also has gastroprotective effects induced by isopulegol appear to be mediated, at least in part, by endogenous prostaglandins, K+ATP channel opening and antioxidant proprieties related to GSH increased.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Exp Parasitol.2018, 194:67-78
  • Front Aging Neurosci.2019, 11:230
  • Medicinal Chemistry Research 2021, 30:1117-1124.
  • Int J Mol Sci.2018, 19(9):E2825
  • Sci Rep.2019, 9(1):18080
  • Front Cell Dev Biol.2021, 9:638174.
  • Nat Prod Sci.2016, 22(2)
  • Oxid Med Cell Longev.2020, 2020:8887251.
  • Molecules.2021, 26(3):695.
  • Antioxidants (Basel).2021, 10(9):1487.
  • Ginsenoside Rg5

    Catalog No: CFN92643
    CAS No: 186763-78-0
    Price: $238/20mg
    Linarin

    Catalog No: CFN98738
    CAS No: 480-36-4
    Price: $40/20mg
    Quercetin-3-O-sophoroside

    Catalog No: CFN90630
    CAS No: 18609-17-1
    Price: $80/20mg
    Coniferin

    Catalog No: CFN98886
    CAS No: 531-29-3
    Price: $288/20mg
    Eupatorin

    Catalog No: CFN97418
    CAS No: 855-96-9
    Price: $158/10mg
    Faculty of Medicine, Federal University of Ceará, Fortaleza, 2009.
    Evaluation of the central nervous system and gastroprotective effects of isopulegol in mice.[Reference: WebLink]
    Isopulegol is a monoterpene alcohol present in the essential oils of various plants, and has been used in the manufacture of fragrances with blossom compositions.
    METHODS AND RESULTS:
    In order to investigate its effects on animal models of CNS actions, Isopulegol was administered to male Swiss mice at single doses of 25 and 50 mg/kg 30 (i.p.) or 60 min (p.o.) before the experiments. Control animals received vehicle (saline 0.9% in 0.3% Tween). For investigating the involvement of GABAA/BZP system, flumazenil was utilized 15 min before the treatments. Monoamines and their metabolites concentration were also investigated in striatum of mice after acute administration of Isopulegol. The results in EMP and hole board tests suggest possible anxiolytic-like effects from Isopulegol, which were reversed by flumazenil pretreatment, indicating probable positive modulation of benzodiazepine-sensitive GABAA receptors. The anxiolytic-like effects were not accompanied by sedation, as reduced locomotion was not observed in open field test. Parameters observed in the forced swimming, tail suspension and pentobarbital sleeping time tests support the idea that Isopulegol possibly presents depressant activity on the CNS. The observed central effects were corroborated by DA and NE decreased levels (without changes in 5-HT levels). In order to verify whether Isopulegol would be able to exert any protector effect in PTZ-induced convulsions, mice received Isopulegol (25, 50, 100 and 200 mg/kg, i.p. or p.o.) or vehicle before PTZ (99 mg/kg, s.c.). The involvement of GABAA/BZP receptors was also investigated by flumazenil pretreatment. Also, it was evaluated whether antioxidant properties from Isopulegol would be related to its possible anticonvulsant effect. Results showed that Isopulegol (100 and 200 mg/kg) presented anticonvulsant and bioprotective effects against PTZ-induced convulsions. At 100 and 200 mg/kg doses, Isopulegol induced marked sedative effect (decreased locomotion in open field test). Flumazenil pretreatment decreased the prolongation of convulsion latency induced by Isopulegol, suggesting a possible involvement of direct activation of benzodiazepine site of GABAA. Isopulegol also significantly prevented PTZinduced increase in lipid peroxidation, preserved catalase activity in normal levels, and prevented the PTZ-induced loss of GSH in hippocampus of mice. In order to investigate whether Isopulegol would be able to promote gastroprotective effects in ethanol- and indomethacin-induced gastric ulcer models, mice received Isopulegol (25, 50, 100 and 200 mg/kg, p.o.) before ethanol (0.2 mL, p.o.) or indomethacin (20 mg/kg, p.o.). A histopathological assessment of stomachs was conducted, as well as possible mechanisms involved in gastroprotective action were also investigated. Isopulegol presented significant gastroprotective effect in both ethanol- and indomethacin-induced ulcer models. This effect was corroborated by the histopathological assay, which showed that pretreatment with Isopulegol was able to inhibit the ethanol-induced microscopically alterations. The pretreatment with indomethacin and glibenclamide was able to reverse the gastroprotection induced by Isopulegol. The PTZ-induced loss of GSH in stomachs and liver was also preserved by pretreatment with Isopulegol.
    CONCLUSIONS:
    These results suggest that the gastroprotective effects induced by Isopulegol appear to be mediated, at least in part, by endogenous prostaglandins, K+ATP channel opening and antioxidant proprieties related to GSH increased.
    Fitoterapia, 2009, 80(8):506-513.
    Effects of isopulegol on pentylenetetrazol-induced convulsions in mice: Possible involvement of GABAergic system and antioxidant activity.[Reference: WebLink]
    The present study investigated the effects of Isopulegol, a monoterpene alcohol, in PTZ-induced convulsions and verified possible involved mechanisms.
    METHODS AND RESULTS:
    Saline, Isopulegol or diazepam were intraperitonealy injected 30 min before PTZ. The latency for development of convulsions and mortality, as well as the mortality protection percentage was recorded. For investigating the involvement of GABAergic system, flumazenil was utilized. The activity of antioxidant enzyme catalase as well as the levels of reduced glutathione and lipid peroxidation were measured in brain hippocampus. Similarly to diazepam, Isopulegol significantly prolonged the latency for convulsions and mortality of mice. All animals were protected against mortality at higher dose of Isopulegol. Flumazenil pretreatment decreased the prolongation of seizure latency induced by both diazepam and Isopulegol, although it was not able to reverse the latency and protection percent for mortality. Isopulegol also significantly prevented PTZ-induced increase in lipid peroxidation, preserved catalase activity in normal levels, and prevented the PTZ-induced loss of GSH in hippocampus of mice.
    CONCLUSIONS:
    These results suggest that the anticonvulsant and bioprotective effects of Isopulegol against PTZ-induced convulsions are possibly related to positive modulation of benzodiazepine-sensitive GABAA receptors and to antioxidant properties.
    Carbohydrate Polymers, 2013, 97(2):546-550.
    β-Cyclodextrin as the suitable molecular container for isopulegol enantiomers.[Reference: WebLink]
    Isopulegol, an insoluble in water and highly volatile compound, due to its neuroactive properties is a potentially important agent for medical applications. Formation of “host–guest” molecular complexes with cyclodextrins would lead to the increase of its water solubility and bioavailability.
    METHODS AND RESULTS:
    Interactions between native cyclodextrins (α, β and γ) and Isopulegol enantiomers were studied in solution proving the formation of inclusion complexes for β- and γ-cyclodextrins. For the more stable complexes with β-cyclodextrin crystal structures were obtained showing the formation of molecular capsules forming molecular container able to accommodate two guest molecules.
    Ginsenoside F5

    Catalog No: CFN95034
    CAS No: 189513-26-6
    Price: $298/20mg
    1,3,6-Tri-O-galloylglucose

    Catalog No: CFN95043
    CAS No: 18483-17-5
    Price: $318/10mg
    Gancaonin N

    Catalog No: CFN95066
    CAS No: 129145-52-4
    Price: $463/5mg
    Atractylochromene

    Catalog No: CFN95162
    CAS No: 203443-33-8
    Price: $318/10mg
    cis-Aegineoside

    Catalog No: CFN95295
    CAS No: N/A
    Price: $413/5mg
    Diosmin Impurity 5

    Catalog No: CFN95311
    CAS No: 122087-66-5
    Price: $318/10mg
    New compound 8

    Catalog No: CFN95341
    CAS No: N/A
    Price: $318/5mg
    Eschweilenol C

    Catalog No: CFN95363
    CAS No: 211371-02-7
    Price: $318/10mg
    4-O-Caffeoyl-3-O-syringoylquinic acid

    Catalog No: CFN95430
    CAS No: 1207645-17-7
    Price: $413/5mg
    Rhamnocitrin 3-galactoside

    Catalog No: CFN95474
    CAS No: 99878-05-4
    Price: $318/10mg